跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OMNIC OCAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OMNIC OCAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA
Approved
STANDARD
OMNIC OCAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA
Astellas Pharma B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 8, 2023
Approval ID
69c1729f888c9a98
Company
Astellas Pharma B.V.
Type
Standard
Approval Details
Approval Id
69c1729f888c9a98
Drug Cima Aemps Name
OMNIC OCAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA
Register Number
6775-2014-01IP
Holder Company Name
Astellas Pharma B.V.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-11-08
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
0,4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Astellas Pharma B.V.
Active Ingredients
TAMSULOSINA HIDROCLORURO
0,4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 8, 2023
Approval ID
69c1729f888c9a98
Type
Standard
Back to CIMA-AEMPS Approvals